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Summary 
Efficient immune responses require interactions between cell adhesion molecules on lymphocytes 
and counter-receptors on antigen presenting cells or target cells. While target-specific receptors 
or ligands have not been identified for natural killer (NK) cells, cell adhesion molecules have 
been implicated in the interaction between NK cell effectors and tumor cell targets.  Herein, 
we describe monodonal antibodies (mAbs) against a carcinoma cell line that efficiently block 
the cytolytic activity of interleukin 2-activated NK cell lines and clones. L280 mAb reacts with 
secretory epithelial cells in normal human tissues, but does not react with hematopoietic cells 
or other tissue types. Biochemical analysis revealed that L280 mAb immunoprecipitates  the ~4,c~6 
integrin, as well as a novel 98-kD glycoprotein, and probably reacts with a carbohydrate epitope 
on these molecules. Involvement of the L280 antigen in cellular immunity is not restricted to 
NK cell-mediated cytotoxicity. L280 mAb also efficiently inhibits aUoantigen-specific cytotoxicity 
against  Colo-205 cells mediated by human histocompatibility leukocyte antigen (HLA)-A2 
alloantigen specific o~B-TCR + and 3,&TCR + cytotoxic T lymphocyte (CTL) clones. Addition- 
ally, we demonstrate that L280 mAb blocks cytotoxicity mediated by influenza peptide-specific 
HLA-restricted CTL clones. These data indicate that the antigen recognized by L280 mAb is 
important in both NK and CTL function, and that an as yet unidentified receptor for this epithelial 
antigen is present on both NK and T lymphocytes. The restricted expression of L280 antigen 
indicates  that this molecule may be important in immune reactions in epithelial tissues. 
T  lymphocytes recognize antigen via the CD3/T cell an- 
tigen receptor complex (1). In addition to the antigen- 
specific receptor, other T cell surface molecules are essential 
for interaction of helper T cells with APC or CTL with target 
cells (2-4). These have been referred to as "accessory" or "cell 
adhesion" molecules. Cell adhesion molecules present on the 
effector T cell can interact with cellular ligands or "counter- 
receptors" on the membranes of APC or target cells. Recent 
studies have indicated that a vast array of membrane struc- 
tures are involved in inter-cellular binding and signaling. In- 
teraction of these accessory molecules can be critical to the 
generation of an immune response. For example, alloantigen 
specific helper T cells fail to produce cytokines in response 
to HLA-DR7 antigen expressed in murine L cells. However, 
cotransfection of HLA-DR7 and CD54 (ICAM-1), a cellular 
ligand for CDll/18 (LFA-1), restores T  cell responsiveness 
(5).  Thus,  antigen-specific  recognition alone may be in- 
suffident to trigger effector function, since additional acces- 
sory molecules are required for an efficient response. 
NK cells are a population of lymphocytes identified by the 
phenotype CD3e-,CD56 + that mediate major histocom- 
patibility complex unrestricted cytotoxicity against  certain 
malignant and virus-infected cells, and produce numerous 
cytokines following immune stimulation (6). The cell sur- 
face receptors on NK cells that are involved in target cell rec- 
ognition have not been identified. There is considerable de- 
bate whether NK cells possess "specific" receptors for targets 
or alternatively whether the cytotoxic function can be initi- 
ated simply by appropriate engagement of cell adhesion mol- 
ecules (7). Nonetheless, as with T cells, cell adhesion mole- 
cules are certainly involved in the interaction between NK 
cells and their targets. Although 82 integrin (CDll/18) and 
CD2 have been implicated in certain NK/target cell interac- 
tions (8-10),  in general the cell surface molecules involved 
in  NK  cell  interactions with  target  cells have  not been 
identified. 
NK  cells  constitutively  express  intermediate  affinity 
receptors for IL-2 and are able to kill a broad spectrum of 
tumor cell targets after activation by Ib2 (11-13). Colo-205 
is a human colon adenocarcinoma cell line that is resistant 
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lysed by IL-2-activated NK cells (12). mAbs were generated 
against this tumor in order to identify the membrane struc- 
tures involved in the interaction between NK cells and carci- 
noma targets. In this report, we describe  mAbs that react 
with normal secretory epithelial tissues and recognize a/34, 
or6 integrin-associated antigen on the membrane of Colo- 
205.  The role of this antigen in NK and CTL cytotoxicity 
is examined. 
Materials and Methods 
HTbridomas and Tumor Cell Lines.  Colo-205,  Colo-320, LoVo, 
and HT-29 are human colon carcinoma  cell lines, ZR 75-1 is a breast 
carcinoma ceil line, U937 is a myeloid leukemia cell line, K562 is 
an erythroleukemia call line, HeLa is an epithdoid carcinoma cell 
line, PA-1 is an ovarian teratocarcinoma cell line, Jurkat and HPB- 
ALL are T leukemia cell lines, Daudi and Raft are Burkitt's lym- 
phoma cell lines, HL-60 is a myeloid leukemia cell line, KGla is 
an early hematopoietic leukemia  cell line, SK-MEL-1  is a melanoma 
cell line, and JY is an EBV-transformed  lymphoblastoid cell line 
(American Type Culture Collection, Rockville, MD). BDMEL-1 
and BDMEL-2 are melanoma ceil lines established from primary 
melanoma tumors generously provided by Drs. Brett Gemlo and 
Anthony Rayner (University of California, San Francisco, CA). 
SK-N-SH is a neuroblastoma cell line generously provided by Drs. 
Roxanne Duan and Wolfgang Sadee (University of  California, San 
Francisco, CA). Colo-205 was determined to express HLA-A2 (Dr. 
Fran Ward, Duke University, Durham, NC personal communica- 
tion).  L279, L280, L281 mAb were generated by immunizing 
BALB/c mice with Colo-205. Immune splenocytes  were fused with 
Sp2/0 and hybridomas selected by growth in azaserine. Hybrid- 
omas were cloned using a FACStar (Becton Dickinson Immuno- 
cytometry Systems, San Jose, CA). Hybridoma isotype was deter- 
mined using rat anti-mouse Ig isotype-specific  mAb, generously 
provided by Mr. David Buck (Becton Dickinson Immunocytom- 
etry Systems). 
l'r  Blood NaturaI Killer  (NK) Cells and NK Clones.  PBMCs 
(Stanford Blood Center, Stanford, CA) were isolated  by Ficoll/Hy- 
paque centrifugation. After plastic adherence and passage through 
nylon wool, NK ceils were enriched by centrifugation on discon- 
tinuous gradients of Percoll (Pharmacia  Fine Chemicals, Piscataway, 
NJ) (12). These NK cell  enriched  peripheral blood preparations  were 
'~30-50% CD3-CD16+,CD56 + NK cells and 50-70% CD3 + T 
cells. Ceils were cultured overnight in RPMI 1640 media (M. A. 
Bioproducts, Walkersville,  MD) supplemented  with 10% FCS (J. R. 
Scientific, Woodland, CA), 1 mM t-glutamine (Gibco Laborato- 
ties, Chagrin Fails,  OH), antibiotics, and 200 IU/ml recombinant 
Ib2 (generously provided by Cetus Corp., Emeryviile, CA) (12). 
CD3e-,CD16 +  ,CD56  + NK clones were established using culture 
conditions described previously (14), with 50 IU/ml recombinant 
ID2 as growth factor. 
Cytotoxic T Lymphocyte (CTL) Lines and Clones.  For genera- 
tion  of anti-Colo-205  CTL, PMBCs (10~/ml) were cocultured 
with irradiated (7,000 tad) Colo-205 ceUs (10S/ml) and irradiated 
(2,500 rad) allogeneic PMBC feeders (4  x  10S/ml) in culture 
medium  (RPMI-1640; M.  A.  Bioproducts)  +  10%  FCS  (JR 
Scientific); 1 mM sodium pyruvate, 1 mM t-glutamine, 100 U/ml 
penicillin, and 100 #g/ml streptomycin) in a 24-well tissue culture 
plate (Falcon Plastics, Lincoln Park, NJ). CTL cell lines were res- 
timulated three times by coculture with irradiated Colo-205 cells 
and assayed  for cytotoxicity. These anti-Colo-205 CTL lines were 
subsequently  cloned  by limiting dilution. The HLA-A2 specific  c~- 
TCR § JS86 (15) and 3,~-TCR  § ES204 (16) CTL clones have been 
described previously. CTL Q66.40 is a CD8 §  + CTL 
clone that was derived from a polyclonal culture described previ- 
ously (17). This clone recognizes  a peptide encompassing  positions 
59 to 62 of the influenza virus matrix protein in conjunction with 
HLA-A2 (S. Verma, H. Spits, and R. de Waal Malefyt, manuscript 
in preparation). CTL used  in these studies  do not express Fc receptors 
for IgG. 
mAbs and Reagents.  Control Ig, anti-CD3 (Leu-4), anti-CD16 
(Leu 11a&c), and anti-CD56 (Len 19) mAb were generously  provided 
by Becton  Dickinson Immunocytometry  Systems.  Anti-HLA-A,KC 
(W6/32) hybridoma was obtained from American Type Culture 
Collection. GRGDSP, GR.GESP, human laminin, and 3E1 mAb 
were purchased from Telios  Pharmaceutical  (San Diego, CA). GoH3 
(18), AIIB2 (19), and J1B5 mAb were generous gifts from Dr. A. 
Sonnenberg (Central Laboratory of the Netherlands Red Cross 
Blood  Transfusion Service, Amsterdam) and  Dr.  C.  Damsky 
(University of California, San Francisco). Anti-~4 mAb 439-9B 
(20) was generously provided by Dr. S. Kennel (Oak Ridge, TN). 
The peptide of the influenza virus matrix protein (MAT 59-68) 
was a generous gift of  Dr. Jonathan Rothbard (Immunologics,  Palo 
Alto, CA). 
Cytotoxicity Assay.  Tumor cell lines (~1.5  x  106 cells) were 
labeled with 100 #Ci SlCr for 3 h, washed, and used as targets 
in a 4-h radioisotope release cytotoxicity assay (21). For antigen- 
pulsing, specific  influenza peptide was added at 20 #M during the 
3-h incubation for SlCr labding. 
Immunohistology.  Frozen  sections of human colon, breast, lung, 
and stomach  tissue  obtained  from normal autopsy tissue  were stained 
with control Ig or L280 mAb at saturating concentrations, fol- 
lowed by horseradish peroxidase conjugated goat anti-mouse Ig 
as a second step. 
Flow Cytometry.  Methods of immunofluorescence and flow 
cytometryhave been described  previously  (21). Flow cytometry was 
performed using a FACScan  |  or FACStar  ~ (Becton Dickinson Im- 
munocytometry Systems). 
Biochemistry.  Colo-205  and HT-29 ceils  were surface  labeled  with 
mI (Amersham Corp., Arlington Heights, IL) and were solubi- 
lized in "Iris buffered saline (TBS, 50 mM "Iris, 150 mM NaC1, 
pH  8.0) containing  1%  NP-40, 20  Kallikrein inhibitor  U/ml 
aprotinin (Sigma Chemical Co., St. Louis, MO), and I mM PMSF 
(Sigma Chemical Co.) (22). Cell lysates  were passed through a 0.2 
ml (bed volume) column of Dowex 1  ￿  8-400 (chloride form; 
Sigma Chemical Co.) equilibrated in TBS to remove  unbound mI, 
and were precleared three times with 10 mg Pansorbin (Calbiochem- 
Behring Corp., San Diego, CA) coated with saturating amounts 
of rabbit anti-mouse Ig serum (22). Lysates  were passed through 
lentil lectin-Sepharose  4B (Pharmada Fine Chemicals) equilibrated 
in loading  buffer (10 mM Tris, 150 mM NaCI, 0.25% NP-40, 0.05% 
NAN3, pH 7.4) and glycoproteins eluted in loading buffer con- 
taining 300 mM 1-O-methyl c~ D-glucopyranoside (Sigma Chem- 
ical Co.). Antigens were immunoprecipitated  using Pansorbin  coated 
with saturating amounts of rabbit anti-mouse Ig and mAb (22). 
Immunoprecipitates  were washed five  times in TBS containing 1% 
NP-40. For removal of N-linked oligosaccharides,  immunoprecipi- 
tates were treated with 65 U/m1 endo-F (New England Nuclear, 
Boston, MA) for 24 h at 37~  in the presence of 1 mM PMSF 
and 50 mM EDTA (23). For reprecipitation experiments, ~zSI-la- 
beled lentil lectin purified Colo-205 glycoproteins were incubated 
for 2 h with 25 #1 Sepharose 4B coupled by CNBr to L280 mAb 
(~3 mg Ig/ml beads) or 3E1 mAb (24). Beads were washed five 
times in 1% NP-40 TBS, and antigen was duted in 50 #150 mM 
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M "Iris, pH 7.6. Eluted antigen  was diluted  to 1 ml in cold 1% 
NP-40 TBS containing  10 mg/ml BSA and 1 mM PMSF (Sigma 
Chemical Co.) and used for reimmunoprecipitation  experiments. 
Samples were analyzed by SDS-PAGE under reducing conditions, 
or by two-dimensional diagonal SDS-PAGE (first dimension non- 
reducing, second dimension reducing) using 7.5 % acrylamide gels 
(22). 
Results and Discussion 
Generation of mA bs Inhibiting Interleulein (IL)-2 Activated Nat- 
ural Killer (NK) Cell Cytotoxicity.  To identify the membrane 
structures involved in the killing of carcinomas by Ib2 acti- 
vated NK cells, mAbs were generated against Colo-205 and 
selected for their ability to inhibit cytotoxicity mediated by 
I1.2 activated NK cells, mAbs, designated L279 (IgG3,K iso- 
type), L280 (IgG1,K) and L281 (IgM, g), were identified that 
efficiently blocked NK cell-mediated cytotoxicity against Colo- 
205 (Fig.  1 A), but not other tumor ceU targets, including 
K562, JY, LoVo, HT-29, and BDMEL-1 (not shown). Potent 
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Figure 1.  Inhibition of NK cell-mediated cytotoxicity. (/1) Ib2-acti- 
rated peripheral blood NK cell preparations were assayed  for cytotoxicity 
against Colo-205 cells  in the presence  of mAb L279 (IgG3), L280 (lgG1), 
L281 (IgM) and control Ig. Effector-to-target  (E/T) ratio was 25:1. Note 
that NK cells do not express Fc receptors that bind routine IgG1 or lgM 
mAb (33). (B) L280 mAb dose-dependent inhibition rIb2-activated pe- 
ripheral blood NK cell-mediated cytotoxicity  against Colo-205. Control 
murine IgG1 mAb was used at 10 #g/m1. E/T was 25:1. 
inhibition  of cytotoxicity was achieved with relatively low 
concentrations of purified L280 mAb (Fig. 1 B). These mAbs 
inhibited the cytolytic activity of polyclonal populations of 
peripheral blood NK cells cultured in II-2, as well as I1-2-de- 
pendent NK clones, established from more than 20 individ- 
uals.  All NK cells lines  that  mediated cytotoxicity against 
Colo-205 were efficiently inhibited with L280 mAb. Since 
L279, L280, and L280 mAbs were all determined to immu- 
noprecipitate the same structure, subsequent experiments were 
performed with  only L280 mAb. 
Distribution of the Antigen Recognized by L280 raAh  A panel 
of in vitro cultured cell lines and normal hematopoietic ceils 
were tested for reactivity with L280 mAb by flow cytom- 
etry. As shown in Fig. 2, L280 mAb was strongly reactive 
with  Colo-205.  However, we failed to detect L280 mAb 
binding to any normal hematopoietic cells (including peripheral 
blood lymphocytes, monocytes, granulocytes, erythrocytes, 
platdets, neutrophils, thymocytes, or bone marrow cells). L280 
mAb also failed to react with PHA lymphoblasts, I1-2-de- 
pendent CTL and NK clones, or any transformed hemato- 
poietic cell lines (including Jurkat, HL-60, K562, U937, KGla, 
HPB-ALL, Daudi, Raji, and several EBV lymphoblastoid cell 
lines). Other nonhematopoietic cell lines examined, including 
several colon carcinoma cell lines (HT-29, Colo-320, and LoVo), 
a neuroblastoma cell line (SK-N-SH), a breast carcinoma (ZK 
75-1), an epitheloid carcinoma cell line (HeLA), an ovarian 
Control  HLA  L280 
10  ~  10 t  1 
FITC Fluorescence 
Figure 2.  Binding  of L280 mAb to Colo-205 cells. Colo-205 cells  were 
stained with FITC-conjugated  IgG1 control, FITC-conjugated  L280 mAb, 
or FrI'C-conjugated anti-HLA-A,B,C. The x axis represents fluorescence 
(four decade  log scale) and the y axis the relative cell number. Histograms 
from cells stained with control mAb (nearest the ordinate) are superim- 
posed over the histogram of cells stained with L280 or anti-HLA mAb, 
as indicated. 
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MEbl,  BDMEL-1, BDMEI.-2),  were also unreactive. 
However, immunohistochemical  staining of normal tissues 
indicated that the antigen recognized by L280 mAb is abun- 
dantly expressed in vivo.  As shown in Fig.  3, L280 mAb 
specifically reacted with secretory  epithelial cells in colon, 
breast, lung and stomach. Secretory  epithdial cells of the 
duodenum and  jejunal mucosa, salivary glands, and skin were 
also stained with this mAb (not shown). In lymphoid tissues, 
(continued) 
L280 mAb prominently stained the epithelial  crypts of the 
palatine tonsil and thymic Hassall's corpusdes (not shown), 
but did not react with hematopoietic cells. Given the broad 
distribution in normal tissues, it was surprising that the car- 
cinoma cell lines other than Colo-205 that were examined 
failed to react with L280 mAb. It is possible that expression 
of the antigen is lost during transformation or during in vitro 
culture. A more extensive examination of primary carcinomas 
before and after culture will be necessary to resolve this issue. 
1574  34,c,6-associated  Epithelial  Antigen Figure 3.  Reactivity  of L280 mAb with tissue. Frozen structures  of human colon (,4 and B), breast (C and D), lung (E and F),  and stomach (G 
and/-/) tissue were stained with control Ig (.4,  C, E, and G) or L280 mAb (B, D, F, and/-/), followed by horseradish peroxidase conjugated  goat 
anti-mouse Ig as a second step. 
Nonetheless,  the antigen recognized by L280 mAb is abun- 
dantly distributed on normal epithelial tissues in vivo, demon- 
strating that the antigen is not "tumor-associated" or restricted 
to expression on the Colo-205  cell line. 
Biochemical Characterization.  Colo-205 cells were surface- 
labeled  with  12Sl, detergent  solubilized  and glycoproteins 
isolated by lentil lectin affinity chromatography.  At least 5 
proteins (170, 150, 135, 118, and 98 kD) were immunopre- 
cipitated  using the L280 mAb (Fig. 4 A), L279,  and L281 
mAb (not shown). Direct comparison of the unfractionated, 
lentil-lectin bound, and nonbinding antigens revealed no sub- 
stantial qualitative differences in the structures  immunopre- 
cipitated with L280 mAb and indicated the L280 mAb reac- 
tive glycoproteins  were essentially  exclusively  in the lentil-lectin 
bound fraction (not shown). Since an initial lentil-lectin chro- 
matography step resulted in substantially lower backgrounds 
in the immunoprecipitation experiments,  we routinely in- 
corporated this step in subsequent experiments. Two-dimen- 
sional  diagonal  gel electrophoresis  (first dimension, non- 
reduced; second dimension, reduced) revealed that the 170-, 
150-, 118-, and 98-kD proteins migrated either on or slightly 
above the diagonal,  indicating the presence of possible in- 
trachain  disulfide  bonds,  but  lack  of interchain disulfide 
linkages to other proteins (Fig. 4 B). However, the 135-kD 
subunit migrated below the diagonal due to the cleavage of 
a small disulfide linked component of,o25 kD, that was only 
revealed in subsequent experiments using gradient gels (not 
shown). 
The 170-, 150-, 135-, 118-kD proteins appeared very similar 
to the fl4,cr6 integrin that is preferentially expressed on colon 
carcinomas (20, 25-27). Location of the 135-kD subunit below 
the diagonal was consistent with the migration of or6 inte- 
grin on diagonal gels, as reported by Hemler and colleagues 
(26). Moreover, as with prior studies describing the f14,ot6 
integrin, the relative labeling intensity of the different chains 
varied between experiments, and in some experiments an ad- 
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ditional band of ,o190 kD was observed. Recent studies have 
indicated that f14 exists in isoforms of several sizes, based on 
proteolytic cleavage of the cytoplasmic segment (28). 
Direct comparative analysis  indicated that while two mAb 
against f14 (3E1 and 439-9B) and two mAbs against ~6 (GoH3 
and JiB5) immunoprecipitated the 170-, 150-, 135-, and 118- 
kD proteins,  only L280 immunoprecipitated an additional 
gp98 subunit (Fig. 4 A). Although 31 integrin is expressed 
on Colo-205  cells, anti-ill mAb did not coimmunoprecipi- 
tare f14, c~6, or gp98 subunits  (not shown). Since a proteo- 
lytic fragment of f14 has been observed to migrate at 85 kD 
(26), further studies were undertaken to provide evidence that 
gp98 is a distinct polypeptide.  As shown in Fig. 5, removal 
of N-linked oligosaccharides with endo-F reduced the mo- 
bility of the f14 and c~6 subunits by 5-10 kD consistent with 
prior studies (25); however, gp98 was diminished to 55 kD. 
This high degree of N-linked glycosylation  dearly distin- 
guishes gp98 from f14 and or6. Peptide mapping experiments 
further indicated that gp98 is distinct from the f14 glycopro- 
tein (not shown). Treatment with neuraminidase to remove 
sialic acid and O-glycanase to remove O-linked oligosaccha- 
rides resulted in only minor changes in mobility of the/34, 
or6, or gp98  subunits  (not shown). 
That f14 and or6 are components of the antigen immuno- 
precipitated by L280 mAb was demonstrated by the ability 
to affinity-purify  the antigen using L280 mAb-Sepharose, elute 
the proteins  and then reimmunoprecipitate the eluted pro- 
teins with anti-fl4, anti-or6 and L280 mAbs (Fig. 6 A). Note 
that while L280 mAb reimmunoprecipitated all of the original 
components of the complex,  anti-fl4  and anti-or6 only im- 
munoprecipitated the higher tool wt structures and not gp98. 
This suggests that anti-fl4  and anti-c~6 are unable to react 
with gp98. L280 mAb directly binds to the o~6,fl4 integrin, 
in the absence of the gp98 glycoprotein, based on the ability 
of L280 mAb to reimmunoprecipitate fl4,ot6 integrin affinity- 
purified from Colo-205 using anti-fl4 Sepharose (Fig. 6 B). Figure 5.  Deglycosylation.  L280 mAb immunoprecipitate  from lz~I-la- 
beled Colo-205 was treated with endo-F and analyzed by SDS-PAGE. 
Figure 4.  Biochemical  analysis. (A) Antigens were immunoprecipitated 
from 12si Colo-205 cells using control Ig (C), L280 mAb, anti-B4 (3E1 
and 439-9B) and anti-or6 (GoH3 and JIB5) and analyzed by SDS-PAGE. 
(B) L280 mAb immunoprecipitate from 12SI-labeled  Colo-205 was ana- 
lyzed by two-dimensional diagonal SDS-PAGE (NR, nonreducing; R, 
reducing). 
However, L280 mAb fails to react with •4,ot6  integrin ex- 
pressed on HT-29, another colon carcinoma cell line that ex- 
presses  the B4,a6  integrin (Fig.  7). 
Sequential immunoprecipitation was undertaken to further 
explore the relationship between reactivity of L280 and the 
/J4,o~6 integrin (Fig. 8). 12si lysates from Colo-205 were im- 
munoprecipitated with L280 mAb, anti-fl4 mAb, or anti-a6 
mAb to remove all reactive structures with the individual 
antibodies. Depletion with anti-fl4 removed all ol6 antigen. 
L280 mAb immunoprecipitated gp98 (and also small amounts 
of several higher tool wt proteins) from this 84 depleted ly- 
sate. After depletion of o~6, residual f14 was immunoprecipi- 
tated with anti-~4, and f14 and gp98 were detected with L280 
mAb.  Similarly, after depletion of antigen with L280,  de- 
tectable amounts of~4 and o~6 remained. These results indi- 
cate that a subset of the B4,ot6 integrin molecules are reac- 
tive with L280 mAb, and that anti-fl4 and anti-oe6 mAb are 
unreactive with gp98.  Moreover, these preclearing experi- 
ments demonstrate that/34,o~6 integrin is a major compo- 
nent  of the  125I-labeled membrane  glycoproteins  reactive 
with L280 mAb. 
Collectively, these results suggest that L280 mAb recog- 
nizes an epitope that is expressed both on the/J4,oL6 integrin 
and the gp98 glycoprotein on the surface of Colo-205. How- 
ever, since L280 mAb failed to react with fl4,cz6 integrin on 
the HT-29 cell line,  the most plausible interpretation is that 
1576  B4,o~6-associated  Epithelial Antigen Figure 7.  Immunoprecipitation  from HTo29. Antigens were immuno- 
precipitated  from lzsI HT-29 and Colo-205  cells using control Ig (C), 
L280 mAb and anti-~4  (439-9B) and analyzed by SDS-PAGE. Immuno- 
precipitation of HT-29 with anti-a6 mAb demonstrated an identical profile 
of bands as shown for anti-34 (not shown).  The minor "~100-kD band 
in the anti-B4 immunoprecipitate  of HT-29 likely represents a proteolytic 
fragment  of B4 or or6, and was not observed in other experiments. 
Figure 6.  R~-immunoprecipitation.  (A) Affinity-purified L280 antigen 
was reimmunoprecipitated  with control Ig (C), L280 mAb, anti-J54 (439- 
9B), or anti-cx6 (J1B5) and analyzed by SDS-PAGE. (/3) Affinity-purified 
L280 antigen (kfi t  mnel) and affinity purified B4,cx6 integrin (right  panel) 
were reimmunoprecipitated  with control Ig (C),  L280 mAb or anti-B4 
(439-9B) and analyzed by SDS-PAGE. 
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L280 mAb reacts with a carbohydrate antigen shared between 
B4,oe6 and gp98. Preliminary attempts to deglycosylate B4,ot6 
and gp98 before binding with L280 mAb provided incon- 
clusive results.  However, a common feature of carbohydrate 
antigens is their resistance to denaturation by boiling, whereas 
polypeptide antigens are often destroyed by this treatment. 
As shown in Fig. 9, the antigenic determinants recognized 
by L280 mAb in fact were resistant to boiling. By contrast, 
reactivity of [34,~6 with anti-[34 and anti-or6 mAbs was la- 
bile to this treatment. However, it should be appreciated that 
if the antigen recognized by L280 is actually carbohydrate, 
this structure apparently is restricted in expression to secre- 
tory epithelial tissues. 
Effect of mAb against [34 and cx6 on Natural Killer (NK) Cell- 
mediated Cytotoxicity.  MAb against c~6 or [34 failed to affect 
the cytotoxicity mediated by NK clones  (Fig.  10) or poly- 
clonal IL-2-activated  NK cell cultures from several donors 
(not shown), demonstrating the specificity of the inhibition 
observed with the L279, L280, and L281 mAb. The mecha- 
nism whereby L280 mAb inhibits NK ceU-mediated cyto- 
toxicity has not as yet been determined. Preliminary studies 
to examine the ability of L280 mAb to affect NK cell con- 
jugate formation with Colo-205 target cells have proven in- 
conclusive. L280 mAb does not modulate expression of the 
antigen from the surface of Colo-205 even after  overnight 
culture in saturating concentrations of mAb (not shown). 
As yet, ligands for the [34,cx6 integrin have not yet been 
identified, although it has been suggested that laminin may 
bind to B4,oL6  on certain cell lines (29). Laminin fails to affect Figure 8.  Sequential immunoprecipitation.  Antigens were depleted from 125[ Colo-205 lysates by repeated immunoprecipitation with L280 mAb 
(left), anti-fl4 mAb (439-9B) (center)  or anti-~x6 mAb (J1-B5) (right). Depleted lysates were then immunoprecipitated with control Ig (C), L280 mAb, 
anti-f34, or anti-c~6, as indicated. 
NK cell-mediated lysis of Colo-205 (Fig.  10) and L280 mAb 
did not prevent the binding of Colo-205 cells to laminin coated 
plates 0. Phillips, unpublished observation). Since many inte- 
grin molecules have been shown to recognize cellular ligands 
via an RGD peptide sequence  (30),  GRGDSP and an inac- 
rive analogue  GRGESP  were assayed for inhibition  of NK 
cytotoxicity against Colo-205, but were ineffective (Fig. 10). 
L280  MAb  Inhibition  of Antigen-specific  T  Cell  Cytotox- 
icity.  The ability of L280 mAb to essentially completely in- 
hibit  NK cell-mediated cytotoxicity against Colo-205  indi- 
Inhibitor 
GRGDSP  '  []  NKclone LG.2 
"'J  []  NK clone LG.1 
G R  G E  S P ~~////~'/'//A 
Laminin ~///////////////////A 
anti-alpha 6  P'////////////////////////A 
anti-Beta 1  V///////////////////////////J 
anti-Beta 4 ~ 
1_280 ~ 
Co  n  t rol ~/////./////,///////////,///A. 
0  20  40  60  80 
Figure 9.  Effect  of boiling on L280 mAb reactivity. 12SI-labded  Colo- 
205 lysates  were placed in a boiling water bath for 5 min before immuno- 
precipitation with control Ig (C), L280 mAb, anti-B4 (439-9B), or anti- 
c~6 (JI-BS) mAb. 
%  Cytotoxicity 
Figure  10.  Effect  of anti-B4 and anti-a6 mAb on NK-cell mediated 
cytotoxicity. NK clones NKLG.1 ([]) and NKLG.2 (m) were assayed  for 
cytotoxicity against Colo-205 cells in the presence of control  Ig, L280 
mAb, GRGDSP peptide, GRGESP control peptide, human laminin, and 
mAb against ~1 (AIIB2), B4 (3E1), o~6 (GoH3) E/T ratio was 3:1. For 
inhibition assays, human laminin, GRGDSP, and GR.GESP were used at 
100/~g/ml and mAb were used at 10/zg/ml or at saturating concentra- 
tions of hybridoma supernatant and were added to the targets 30 min be- 
fore effector cells. 
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L280 mAb 
[]  Colo 
[]  JY 
￿9  Colo-PeptJde 
[]  JY-Peptide 
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Figure 12.  Effect  of L280 mAb on influenza peptide-specific, HLA-A2 
restricted CTL. Influenza peptide specific, HLA-A2 restricted CTL Q66.40 
was assayed for cytotoxicity against slCr-labcled  J'Y B lymphobhstoid ceUs 
([], []) and Colo-205 calls (El, m) that were preincubated in media (I-1, 
[]) or media containing  20/~M influenza matrix peptide 59-68 (m, [~). 
Control lg or L280 mAb were added to the targets at 5/~g/ml 30 rain 
before CTL effectors. E/T ratio  was 10:1. 
Figure 11.  Effect  of L280 mAb on alloantigen specific CTL. (.4) CTL 
lines generated from mixed lymphocyte response cultures of PBMC with 
irradiated Colo-205 cells were assayed for cytotoxicity against slCr-labeled 
Colo-205 cells in the presence or absence of control Ig (m), L280 mAb 
([]), anti-HLA-A,B,C  (~),  or anti-CD3 (Fill). All mAbs were used at 
5 ~g/ml. E/T ratio was 25:1. Two experiments are shown. (B) HLA-A2 
alloantigen-specific CTL clones generated against an EBV-transformed B 
lymphoblastoid cell line were assayed  for cytotoxicity against stCr-labeled 
JY B lymphoblastoid cells and Colo-205 in the presence of control Ig or 
L280 mAb (5/~g/ml). JS86 (.)  expresses an c~-TCR, whereas ES204 
(m) expresses a "y~-TCR. E/T ratio  was 5:1. 
cates that the L280 antigen must interact with a receptor 
or cellular ligand present on the surface of NK cells.  The 
"target-specific" receptors on NK cells are unknown; there- 
fore, it is impossible to distinguish between the possibilities 
that the L280 antigen on Colo-205 serves as a "target-antigen" 
for NK cells or serves a more general role as an accessory 
cell molecule. Since the TcR is well characterized, we under- 
1579  Phillips et al. 
took experiments to determine whether L280 mAb affects 
specific  immune interactions between T  lymphocytes and 
Colo-205  cells. 
CTL were generated against Colo-205 cells in a mixed lym- 
phocyte/tumor cell culture. CTL lines were established that 
demonstrated cytotoxicity against Colo-205 (Fig.  11). Cyto- 
toxicity mediated by these CTL cell lines was inhibited by 
anti-CD3  and  anti-HLA-mAbs,  demonstrating  that  the 
effector cells  were CD3 +  CTL  and  likely recognized al- 
logeneic HLA on the Colo-205 targets. L280 mAb efficiently 
blocked CTL-mediated cytotoxicity against Colo-205 targets. 
CD8 +  CTL  clones  established  from these polyclonal cell 
lines also lysed Colo-205 cells and were blocked by anti-CD3, 
anti-HLA, anti-CD8 and L280 mAbs (not shown). These 
results dearly demonstrated that the antigen identified by L280 
mAb participates in immune interactions between CTL and 
Colo-205. Since antigen-specific recognition is undoubtedly 
mediated by the TCR, these findings suggest that the L280 
antigen serves an accessory role and that the receptor for L280 
antigen is present on T lymphocytes in addition to NK cells. 
While experiments using CTL generated against Colo- 
205  demonstrate that the L280 antigen can function in T 
cell interactions,  it is possible  that this is a rare event and 
that T  cells capable  of using this accessory molecule were 
selected in vitro during the MLR.  Therefore, to obtain an 
unbiased assessment, CTL clones generated against B lym- 
phoblastoid cell lines were tested for inhibition with L280 
mAb (Fig.  11). Colo-205 expresses HLA-A2, therefore sev- 
eral weU-characterized HLA-A2 alloantigen specific CTL clones 
were available for analysis. CTL clones JS86 (15) and ES204 
(16) are HLA-A2 specific, and express otl3-TCR and 3~-TCR, 
respectively. These effectors killed Colo-205,  as well as JY, 
an HLA-A2 bearing B lymphoblastoid cell line. Cytotoxicity against Colo-205, but not JY, was essentially completely in- 
hibited by L280 mAb. Since these alloantigen-specific CTL 
lines were selected and re-stimulated using B lymphoblastoid 
cells, there was no preselection for use of the L280 accessory 
cell molecule. Therefore, we conclude that the receptor for 
L280 antigen is expressed on CTL without deliberate induc- 
tion or selection. 
Since the physiological role of alloantigen recognition is 
unclear, further studies were undertaken to determine whether 
the L280 antigen is also involved in HLA-restricted, peptide- 
specific T  cell recognition.  CTL Q66.40 is a CD8 + , c~- 
TCR +  T  cell  clone  that  specifically recognizes  influenza 
virus matrix peptide 59-68 in conjunction with HLA-A2 (S. 
Verma, H. Spits, and R. de Waal Malefyt, manuscript in prep- 
aration). As shown in Fig. 12, CTL Q66.40 did not kill JY 
or Colo-205. However, strong cytolytic activity was observed 
against these targets after pre-incubated with specific influenza 
peptide. L280 mAb efficiently blocked HLA-A2 restricted, 
peptide-specific lysis  of Colo-205,  but not JY  targets. 
In summary, we have identified a novel accessory cell mol- 
ecule that is involved in both NK and T cell-mediated cyto- 
toxicity. Given the distribution of staining with L280 mAb, 
this molecule may participate in the interaction between lym- 
phocytes and epithelial cells in numerous tissues and may be 
of relevance in CTL or NK cell-mediated immunity against 
virus-infected epithelial cells.  Biochemical analysis suggests 
that the epitope recognized by L280 mAb is possibly carbo- 
hydrate in nature and is expressed on both the ~4,ct6 inte- 
grin, as well as another previously unidentified glycoprotein, 
designated gp98. The L280 antigen may interact with an as 
yet unknown counter-receptor (or ligand) on the membrane 
of NK and ot~-TCR + and ),/~-TCR + T cells. If the L280 an- 
tigen is a carbohydrate,  its receptor on lymphocytes could 
conceivably possess lectin-binding domains, similar to the re- 
cently described lectin cell adhesion molecule family of cell 
adhesion molecules (31, 32). Alternatively, it is possible that 
while L280 mAb reacts with a carbohydrate epitope, the pro- 
tein attached to this oligosaccharide may in fact be respon- 
sible for the interaction. Therefore, further studies are neces- 
sary to explore the role of~4, ct6 integrin in possible epithelial 
ceil/lymphocyte interactions, as well as to elucidate the struc- 
ture and function of the gp98 glycoprotein. 
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